chevron_leftBack
As of 20 June 2026, Sunhawk Vision Biotech, Inc. has a market cap of $96.28M USD, ranking #25840 globally and #1419 in Taiwan.
It ranks #2315 in the Healthcare sector, and #445 in the Biotechnology industry.
Key Stats
Market Cap
$96.28MUSD
3.04B TWD
Enterprise Value
$83.72MUSD
2.65B TWD
EBITDA (TTM)
-$5.5MUSD
-173.87M TWD
Net Income (TTM)
-$5.45MUSD
-172.39M TWD
PB Ratio
6.5
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
Founded
2019
Website
sunhawkvision.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 21% | 17% | 12% | -17% | -38% | -58% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
7759
視航生物醫學股份有限公司
ISIN: TW0007759003
Shares Out.:
Shares Outstanding:
70.068M1
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
43.45 TWD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Sunhawk Vision Biotech, Inc.
Sunhawk Vision Biotech, Inc. operates as a drug development company that develops microRNA therapeutic eye drops. Its flagship product is SHJ002 eye drops. Sunhawk Vision Biotech, Inc. was founded in 2019 and is based in Taipei, Taiwan.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TWSE: 6919
|
$5.46B
6K%
172.76B TWD
|
-
|
|
TWSE: 6949
|
$1.61B
2K%
50.93B TWD
|
-
|
|
TPEX: 6696
|
$1.08B
1K%
34.04B TWD
|
-
|
|
TWSE: 7827
|
$726.25M
654%
22.97B TWD
|
-
|
|
|
TPEX: 7827
|
$600.25M
523%
18.98B TWD
|
-
|
|
TPEX: 06891
|
$571.26M
493%
18.06B TWD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: AMGN
|
$182.42B
189K%
|
23.9
|
|
NASDAQ: GILD
|
$159.92B
166K%
|
19.0
|
|
EBR: ARGX
|
$47.43B
49K%
41.39B EUR
|
39.9
|
|
KRX: 207940
|
$44.23B
46K%
68.19T KRW
|
35.5
|
|
ASX: CSL
|
$42.27B
44K%
60.27B AUD
|
29.3
|
|
SIX: LONN
|
$41.88B
43K%
33.71B CHF
|
37.2
|
chevron_leftBack